Abingworth’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Abingworth’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,896	Closed	-$4K	–	22
2016 Q2	$4K	Hold	7,896	–	–	﹤0.01%	20
2016 Q1	$21K	Hold	7,896	–	–	0.02%	19
2015 Q4	$24K	Hold	7,896	–	–	0.01%	18
2015 Q3	$35K	Buy	+7,896	New	+$46.4K	0.02%	17
2014 Q4	–	Sell	-7,896	Closed	-$56K	–	17
2014 Q3	$56K	Buy	+7,896	New	+$68.3K	0.03%	13

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Abingworth's EPRS Position: Q3 2016 in Review

Abingworth sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 7,896 shares — an estimated $4K sold.

Abingworth first reported a position in EPRS in Q3 2014 and held it in 5 quarters. The position peaked at $56K in Q3 2014. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Abingworth reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Abingworth sold 7,896 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $4K.
Abingworth first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 5 quarters.
Abingworth's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $56K in Q3 2014.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Abingworth's 13F filing for Q3 2016, filed 14 Nov 2016.